Unusual interferon gamma measurements with quantiFERON-TB gold and quantiFERON-TB gold in-tube tests

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Powell III, Richard D ^a   Whitworth, William C ^a   Bernardo, John ^b   Moonan, Patrick K ^a   Mazurek, Gerald H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; BACTERIAL ANTIGEN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MITOGENESIS; PROTEIN BLOOD LEVEL; TUBERCULOSIS; ARTIFACT; BLOOD; BLOOD ANALYSIS; IMMUNOLOGY; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; REPRODUCIBILITY; SECRETION;

MYCOBACTERIUM TUBERCULOSIS;

ANTIGENS, BACTERIAL; ARTIFACTS; BLOOD CHEMICAL ANALYSIS; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS;

EID: 79958166158     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020061     Document Type: Article

References (19)

1. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A, (2008) Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 177: 1164-1170.
2. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, et al. (2010) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection- United States, 2010. MMWR Recomm Rep 59: 1-25.
3. National Institute for Health and Clinical Excellence (2011) Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. March 2011 Available: http://guidance.nice.org.uk/CG117. Accessed 2011 May 12.
4. Cellestis Limited (2007) QuantiFERON®-TB Gold: Package Insert. Carnegie, Victoria, Australia, Cellestis Limited Available: http://www.cellestis.com/IRM/Company/ShowPage.aspx?CPID=1247. Accessed 2011 May 12.
5. Cellestis Limited (2010) QuantiFERON®-TB Gold In-Tube: Package Insert. Carnegie, Victoria, Australia, Cellestis Limited Available: http://www.cellestis.com/IRM/Content/pdf/QuantiFeron%20US%20VerG_Jan2010%20NO%20TRIMS.pdf. Accessed 2011 May 12.
6. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, et al. (2004) Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170: 59-64.
7. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, et al. (2007) Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 45: 837-845.
8. Cobanoglu N, Ozcelik U, Kalyoncu U, Ozen S, Kiraz S, et al. (2007) Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers. Int J Tuberc Lung Dis 11: 1177-1182.
9. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, et al. (2005) Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293: 2746-2755.
10. Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, et al. (2005) Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 172: 631-635.
11. Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, et al. (2005) Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 115: 2480-2488.
12. Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, et al. (2007) Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis 45: 826-836.
13. Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, et al. (2008) Interferon-gamma Release Assays for Diagnosing Mycobacterium tuberculosis Infection in Renal Dialysis Patients. Clin J Am Soc Nephrol 3: 1357-1363.
14. Aagaard C, Brock I, Olsen A, Ottenhoff TH, Weldingh K, et al. (2004) Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex. J Infect Dis 189: 812-819.
15. Brock I, Weldingh K, Leyten EM, Arend SM, Ravn P, et al. (2004) Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 42: 2379-2387.
16. Leyten EM, Mulder B, Prins C, Weldingh K, Andersen P, et al. (2006) Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis-specific peptides for diagnosis of recent infection with M. tuberculosis after accidental laboratory exposure. J Clin Microbiol 44: 1197-1201.
17. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, et al. (2006) Latent Tuberculosis in HIV positive, diagnosed by the M. tuberculosis Specific Interferon Gamma test. Respir Res 7: 56.
18. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M, (2009) Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE 4: e8517.
19. Zwerling A, van den HS, Scholten J, Cobelens F, Menzies D, et al. (2011) Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax In press.